Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery

References

• Akhtar S, Benter IF. (2007). Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest, 117, 3623–3632.
   PubMed Web of Science ®Google Scholar
• Arthanari Y, Pluen A, Rajendran R, Aojula H, Demonacos C. (2010). Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells. J Control Release, 145, 272–280.
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM. (2001). Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res, 61, 5736–5740.
   PubMed Web of Science ®Google Scholar
• Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. (2002). Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun, 296, 1000–1004.
   PubMed Web of Science ®Google Scholar
• Caplen NJ. (2003). RNAi as a gene therapy approach. Expert Opin Biol Ther, 3, 575–586.
   PubMed Web of Science ®Google Scholar
• Ding W, Hattori Y, Higashiyama K, Maitani Y. (2008). Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. Int J Pharm, 354, 196–203.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494–498.
   PubMed Web of Science ®Google Scholar
• Ferrara N. (2002). VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer, 2, 795–803.
   PubMed Web of Science ®Google Scholar
• Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, Harel-Bellan A, Clézardin P, Cabon F. (2003). SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res, 63, 3919–3922.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806–811.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182–1186.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1, 27–31.
   PubMed Web of Science ®Google Scholar
• Hammond SM, Bernstein E, Beach D, Hannon GJ. (2000). An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 404, 293–296.
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. (2008). Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release, 129, 107–116.
   PubMed Web of Science ®Google Scholar
• Lange T, Guttmann-Raviv N, Baruch L, Machluf M, Neufeld G. (2003). VEGF162, a new heparin-binding vascular endothelial growth factor splice form that is expressed in transformed human cells. J Biol Chem, 278, 17164–17169.
   PubMed Web of Science ®Google Scholar
• Lares MR, Rossi JJ, Ouellet DL. (2010). RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol, 28, 570–579.
   PubMed Web of Science ®Google Scholar
• Lee RJ, Huang L. (1997). Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst, 14, 173–206.
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306–1309.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Kubo H, Murata H, Uhara H, Takata M, Shibata S, Yasue S, Sakakibara A, Tomita Y, Kageshita T, Kawakami Y, Mizuno M, Yoshida J, Saida T. (2008). A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. Jpn J Clin Oncol, 38, 849–856.
   PubMed Web of Science ®Google Scholar
• Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD. (1991). Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA, 88, 5819–5823.
   PubMed Web of Science ®Google Scholar
• Percot A, Briane D, Coudert R, Reynier P, Bouchemal N, Lièvre N, Hantz E, Salzmann JL, Cao A. (2004). A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning. Int J Pharm, 278, 143–163.
   PubMed Web of Science ®Google Scholar
• Reynier P, Briane D, Coudert R, Fadda G, Bouchemal N, Bissieres P, Taillandier E, Cao A. (2004). Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours. J Drug Target, 12, 25–38.
   PubMed Web of Science ®Google Scholar
• Schatzlein AG. (2001). Non-viral vectors in cancer gene therapy: principles and progress. Anticancer Drugs, 12, 275–304.
   PubMed Web of Science ®Google Scholar
• Scott PA, Gleadle JM, Bicknell R, Harris AL. (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer, 75, 706–712.
   PubMed Web of Science ®Google Scholar
• Shi W, Siemann DW. (2004). Simultaneous targeting of VEGF message and VEGF receptor signaling as a therapeutic anticancer approach. Anticancer Res, 24, 213–218.
   PubMed Web of Science ®Google Scholar
• Slimani H, Guenin E, Briane D, Coudert R, Charnaux N, Starzec A, Vassy R, Lecouvey M, Perret YG, Cao A. (2006). Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1. J Drug Target, 14, 694–706.
   PubMed Web of Science ®Google Scholar
• Sørensen DR, Leirdal M, Sioud M. (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 327, 761–766.
   PubMed Web of Science ®Google Scholar
• Spelios M, Kearns M, Savva M. (2010). From gene delivery to gene silencing: plasmid DNA-transfecting cationic lipid 1,3-dimyristoylamidopropane-2-[bis(2-dimethylaminoethane)] carbamate efficiently promotes small interfering RNA-induced RNA interference. Biochemistry, 49, 5753–5759.
   PubMed Web of Science ®Google Scholar
• Stein CA, Hansen JB, Lai J, Wu S, Voskresenskiy A, Høg A, Worm J, Hedtjärn M, Souleimanian N, Miller P, Soifer HS, Castanotto D, Benimetskaya L, Ørum H, Koch T. (2010). Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res, 38, e3.
   PubMed Web of Science ®Google Scholar
• Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. (2004). A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res, 64, 3365–3370.
   PubMed Web of Science ®Google Scholar
• Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M, Saito R, Nobayashi M, Wakabayashi T. (2004). Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum Gene Ther, 15, 77–86.
   PubMed Web of Science ®Google Scholar
• Zabner J. (1997). Cationic lipids used in gene transfer. Adv Drug Deliv Rev, 27, 17–28.
   PubMed Web of Science ®Google Scholar
• Zetter BR. (1998). Angiogenesis and tumor metastasis. Annu Rev Med, 49, 407–424.
   PubMed Web of Science ®Google Scholar